About-us technologies products Clinical-trials collaborations news careers contact-us
About Philogen

Philogen is a Swiss-Italian integrated biotechnology company founded in 1996, with the mission to develop innovative biopharmaceuticals for the treatment of angiogenesis-related disorders.....>>

About Philochem

Philochem is a fully owned daughter company of Philogen and represents the Discovery Unit of the Philogen group.

Philochem is based in Otelfingen (Zurich, Switzerland).>>

Recent News

Siena (Italy),
March 7th, 2014

Philogen is awarded the “Premio + Impresa + Innovazione + Lavoro” by the Tuscany Regional Council for its development of Darleukin, the new immunocytokine for the treatment of metastatic melanoma.

Upcoming Events

Turin, Italy,
10th-12th March 2014

Philogen will be participating in the BIOEurope event in Turin, 10th-12th March 2014.